Rigidity in Parkinson's Disease: The Objective Effect of Levodopa. [PDF]
Mov DisordFalletti M +8 more
europepmc +1 more source
PT 536.01: Neurosciences for the Health Professions [PDF]
, 2009 Fehrer, Steven +2 more
core +1 more source
Response to letter to the editor regarding "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries". [PDF]
BMC NeurolAntonini A +10 more
europepmc +1 more source
Levodopa-synergistic CBT intervention improves Parkinson's disease with anxiety disorder by regulating the BDNF/PI3K/AKT pathway. [PDF]
Neurol SciJi N +6 more
europepmc +1 more source
Using computer modeling to find new LRRK2 inhibitors for parkinson's disease. [PDF]
Sci RepGarcía MC +6 more
europepmc +1 more source
[1 model for the prognosis of anticonvulsive and antiparkinson agents].
Farmatsevtychnyi zhurnal, 1979 N O, Ianishevs'ka, R M, Piniazhko
openaire +1 more source
[Abuse of the antiparkinson agents biperidin and benzhexol].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1983 openaire +1 more source
Some New Piperazino Derivatives as Antiparkinson and Anticonvulsant Agents
Archiv der Pharmazie, 1983 AbstractThe piperazino derivatives 1–7 were synthesized and evaluated for their antiparkinson activity on oxotremorine‐induced tremors and reserpine‐induced rigidity. The same compounds were screened for their anticonvulsant activity. Compounds 1, 3, 4 and 5 showed promising antiparkinson activity.
Manju Sharma +5 more
openaire +5 more sources